Lung cancer: developments, concepts, and specific aspects of the new WHO classification
- 890 Downloads
Diagnostic methods and algorithms for the diagnosis of pulmonary neoplasms have considerably changed over the recent years. Based on large-scale molecular characterization studies and the development of targeted therapies, precise morphological, immunohistochemical, and molecular pathological tumor subtyping is now of utmost importance for evidence-based treatment decisions. Changes of diagnostic concepts initially referred to biopsies and cytology specimens but are now also transferred to resection specimens.
This review is focused on recent developments in morphological and immunohistochemical subtyping of pulmonary neoplasms and concepts of tumor progression. It also provides perspectives on relevant changes of diagnostic concepts within the context of the new WHO classification.
It becomes apparent that a three-step diagnostic concept based on morphology, immunohistochemistry, and molecular pathology is important to meet the requirements of an increasingly more complex, interdisciplinary care of lung cancer patients and to allow for reliable, clinically meaningful tumor diagnoses.
KeywordsLung cancer Diagnosis Classification Immunohistochemistry Molecular pathology
Compliance with Ethical Standards
Conflict of interest
- Fernandez-Cuesta L, Peifer M, Lu X et al (2014b) Cross-entity mutation analysis of lung neuroendocrine tumors sheds light into their molecular origin and identifies new therapeutic targets. In: Proceeding of the American Association for Cancer Research. Annual Meeting 2014, vol. 1531, San Diego, USAGoogle Scholar
- Kadota K, Yeh YC, Sima CS et al (2014) The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype. Mod Pathol 27:690–700CrossRefPubMedPubMedCentralGoogle Scholar
- Travis WD, Brambilla E, Müller-Hermeling K, Harris CC (2004) WHO classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart, 3rd edn. IARC Press, LyonGoogle Scholar
- Travis WD, Brambilla E, Noguchi M et al (2013) Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med 137:685–705CrossRefPubMedGoogle Scholar
- Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (2015) WHO classification of tumours of the lung, pleura, thymus and thymus, 4th edn. IARC, LyonGoogle Scholar
- Warth A, Muley T, Meister M et al (2012a) The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 30:1438–1446CrossRefPubMedGoogle Scholar